Kyongbo Pharmaceutical Co., Ltd
214390.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$131.49B
Close$
Share Statistics
| Market cap | $131.49 Billion |
|---|---|
| Enterprise Value | $283.11 Billion |
| Dividend Yield | $50.00 (0.91%) |
| Earnings per Share | $7.63 |
| Beta | 0.31 |
| Outstanding Shares | 23,907,000 |
Return
| Return on Equity | 3.38% |
|---|---|
| Return on Assets | 1.35% |
| Return on Invested Capital | 1.51% |
Valuation & Multiples
| P/E Ratio | 26.44 |
|---|---|
| PEG | -9.74 |
| Price to Sales | 0.46 |
| Price to Book Ratio | 0.88 |
| Enterprise Value to Revenue | 1.01 |
| Enterprise Value to EBIT | 107.52 |
| Enterprise Value to Net Income | 56 |
| Total Debt to Enterprise | 0.56 |
| Debt to Equity | 1.08 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Kyongbo Pharmaceutical Co., Ltd
505 employees
CEO: Tae-Young Kim Established in 1987 and based in Asan, South Korea, Kyongbo Pharmaceutical Co., Ltd is a key player in the South Korean pharmaceutical market, primarily focusing on the production and distribution of active pharmaceutical ingredients (AP...